³»¿ë |
4¿ù 21ÀÏ ¼ö¿äÃʵ¶È¸ °øÁö
PDE5 inhibitor and BPH/LUTS
ÁÂÀå: ±èÇö¿ì ±³¼ö
¹ßÇ¥ :
R4: À̵¿¼· Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia. Curr Opin Urol. 2010;20(1):49-54
R3: ÃÖÁøºÀ Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia? BJU Int. 2009 ;104(4):511-7
ÀϽà : 2010³â 5¿ù 26ÀÏ ¿ÀÈÄ 5½Ã 30ºÐ
Àå¼Ò : ¼º¸ðº´¿ø 4Ãþ ´ë°´ç
ÄÁÆÛ·±½ºÈÄ µ¿¹®ÃÑȸ°¡ ÀÖ½À´Ï´Ù. |
|